Evidence map›Paper›PMID 31387911›Full record

ArticlemBio2019

Gamma Interferon Alters Junctional Integrity via Rho Kinase, Resulting in Blood-Brain Barrier Leakage in Experimental Viral Encephalitis.

Stephanie Bonney, Scott Seitz, Caitlin A Ryan, Kenneth L Jones, Penny Clarke, Kenneth L Tyler, Julie A Siegenthaler

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Case Report: DisseminatedFrontiers in immunology · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stephanie BonneyDepartment of Pediatrics, Section of Developmental Biology, University of Colorado, School of Medicine, Aurora, Colorado, USA.
Scott SeitzMicrobiology Graduate Program, University of Colorado, School of Medicine, Aurora, Colorado, USA.
Caitlin A RyanDepartment of Pediatrics, Section of Developmental Biology, University of Colorado, School of Medicine, Aurora, Colorado, USA.
Kenneth L JonesDepartment of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplant, University of Colorado, School of Medicine, Aurora, Colorado, USA.
Penny ClarkeDepartment of Neurology, University of Colorado, School of Medicine, Aurora, Colorado, USA.
Kenneth L TylerDepartment of Neurology, University of Colorado, School of Medicine, Aurora, Colorado, USA ken.tyler@ucdenver.edu julie.siegenthaler@ucdenver.edu.
Julie A SiegenthalerDepartment of Pediatrics, Section of Developmental Biology, University of Colorado, School of Medicine, Aurora, Colorado, USA ken.tyler@ucdenver.edu julie.siegenthaler@ucdenver.edu.
University of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Transgenic and Gene Targeting CoreP30AR057212 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI KOCH, PETER J. · 2009 to 2018
$6.2M
Retinoic Acid in Development of CNS VasculatureR01NS098273 · NINDS · UNIVERSITY OF COLORADO DENVER · PI SIEGENTHALER, JULIE · 2016 to 2025
$3.2M
Identification and evaluation of novel therapeutic targets for virus-induced neuronal diseaseR33AI101064 · NIAID · UNIVERSITY OF COLORADO DENVER · PI TYLER, KENNETH L. · 2014 to 2016
$1.4M
Cellular genes and signaling pathways as therapeutic targets for virus-induced CNR01NS076512 · NINDS · UNIVERSITY OF COLORADO DENVER · PI TYLER, KENNETH L. · 2011 to 2014
$1.4M
Vascular instability in encephalitisF31NS100565 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BONNEY, STEPHANIE · 2017 to 2019
$82k
BLRD VA I01 BX000963NCI NIH HHS P30 CA046934NIAID NIH HHS R33 AI101064NIAMS NIH HHS P30 AR057212NINDS NIH HHS F31 NS100565NINDS NIH HHS R01 NS076512NINDS NIH HHS R01 NS098273
6 · The paper itself

Abstract

Blood-brain barrier (BBB) breakdown is a hallmark of many diseases of the central nervous system (CNS). Loss of BBB integrity in CNS diseases such as viral encephalitis results in the loss of nutrient/oxygen delivery, rapid infiltration of immune cells, and brain swelling that can exacerbate neuronal injury. Despite this, the cellular and molecular mechanisms that underlie BBB breakdown in viral encephalitis are incompletely understood. We undertook a comprehensive analysis of the cellular and molecular signaling events that induce BBB breakdown in an experimental model of virus-induced encephalitis in which neonatal mice are infected with reovirus (serotype 3 strain Abney). We show that BBB leakage during reovirus infection correlates with morphological changes in the vasculature, reductions in pericytes (BBB supporting cells), and disorganization of vascular junctions. Pathway analysis on RNA sequencing from brain endothelial cells identified the activation of interferon (IFN) signaling within the brain vasculature following reovirus infection. Our

Indexed as

AnimalsBlood-Brain BarrierBrainDisease Models, AnimalEncephalitis, ViralEndothelial CellsFemaleHumansInterferon-gammaMaleMammalian orthoreovirus 3MiceReoviridae Infectionsrho-Associated KinasesInterferon-gammarho-Associated KinasesRock1 protein, mouseRock2 protein, mouseblood-brain barrierencephalitisinterferon gammareovirusviral encephalitis

Identifiers

PMID31387911
PMCPMC6686045
OpenAlexW2965238134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.